Related Experiment Video
Updated: Feb 2, 2026

Whole-cell MALDI-TOF Mass Spectrometry is an Accurate and Rapid Method to Analyze Different Modes of Macrophage Activation
Published on: December 26, 2013
An Accurate and Effective Method for Measuring Osimertinib by UPLC-TOF-MS and Its Pharmacokinetic Study in Rats
Song-Tao Dong1,2, Ying Li3, Hao-Tian Yang4
1National Clinical Drug Monitoring Center, Department of Pharmacy, Hebei Province General Center, Shijiazhuang 050051, China. dongsongtao8886@163.com.
Abstract:
Osimertinib, a new-generation inhibitor of the epidermal growth factor, has been used for the clinical treatment of advanced T790M mutation-positive tumors. In this research, an original analysis method was established for the quantification of osimertinib by ultra-performance liquid chromatography with time of flight mass spectrometry (UPLC-TOF-MS) in rat plasma. After protein precipitation with acetonitrile and sorafinib (internal standard, IS), they were chromatographed through a Waters XTerra MS C18 column. The mobile phase was acetonitrile and water (including 0.1% ammonia). The relative standard deviation (RSD) of the intra- and inter-day results ranged from 5.38 to 9.76% and from 6.02 to 9.46%, respectively, and the extraction recovery and matrix effects were calculated to range from 84.31 to 96.14% and from 91.46 to 97.18%, respectively. The results illustrated that the analysis method had sufficient specificity, accuracy and precision. Meanwhile, the UPLC-TOF-MS method for osimertinib was successfully applied into the pharmacokinetics of SD rats.
Insights
A new method quantifies osimertinib in rat plasma using ultra-performance liquid chromatography-time of flight mass spectrometry (UPLC-TOF-MS). This validated technique accurately measures osimertinib, aiding pharmacokinetic studies.
Area of Science:
- Analytical Chemistry
- Pharmacology
- Biochemistry
Background:
- Osimertinib is a key treatment for advanced epidermal growth factor receptor (EGFR) T790M mutation-positive tumors.
- Accurate quantification of osimertinib is crucial for understanding its behavior in vivo.
- Existing analytical methods may require enhancement for specific applications like pharmacokinetic studies.
Purpose of the Study:
- To develop and validate an original analytical method for quantifying osimertinib in rat plasma.
- To assess the method's specificity, accuracy, and precision.
- To apply the validated method to pharmacokinetic studies in Sprague-Dawley (SD) rats.
Main Methods:
- Ultra-performance liquid chromatography with time of flight mass spectrometry (UPLC-TOF-MS) was employed.
- Acetonitrile was used for protein precipitation, with sorafinib as the internal standard.
- Chromatography was performed on a Waters XTerra MS C18 column using a mobile phase of acetonitrile and water with 0.1% ammonia.
Main Results:
- The developed UPLC-TOF-MS method demonstrated high specificity, accuracy, and precision.
- Intra-day and inter-day relative standard deviations (RSD) were within acceptable ranges (5.38–9.76% and 6.02–9.46%, respectively).
- Extraction recovery (84.31–96.14%) and matrix effects (91.46–97.18%) were within acceptable limits.
Conclusions:
- A robust and validated UPLC-TOF-MS method for osimertinib quantification in rat plasma was successfully established.
- The method's performance characteristics confirm its suitability for analytical purposes.
- The validated method was effectively utilized in the pharmacokinetic analysis of osimertinib in SD rats.
More Related Videos
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
Published on: May 20, 2013
10:22Improved UPLC-UV Method for the Quantification of Vitamin C in Lettuce Varieties Lactuca sativa L. and Crop Wild Relatives Lactuca spp.
Published on: June 30, 2020
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
MALDI-TOF Mass Spectrometry
Biological Effects of Radiation
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetics: Overview